China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Sustainability Profile
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., commonly referred to as Sanjiu, is a leading player in the pharmaceutical industry, headquartered in China. Established in 1992, the company has made significant strides in the healthcare sector, focusing on the research, development, and manufacturing of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Sanjiu is renowned for its diverse portfolio of core products, including herbal medicines, over-the-counter drugs, and health supplements. The company’s commitment to innovation and quality has positioned it as a trusted name in the market, achieving notable milestones such as extensive research collaborations and a robust distribution network. Sanjiu's dedication to enhancing public health through effective and accessible healthcare solutions underscores its prominent market position, making it a key contributor to the pharmaceutical landscape in China and beyond.
DitchCarbon Score
How does China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s score of 30 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of China Resources Pharmaceutical Group Limited, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. This lack of specific data suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. The emissions data and performance metrics are cascaded from its parent company, China Resources Pharmaceutical Group Limited, which operates at a higher corporate level. This relationship may provide insights into the broader sustainability initiatives and targets set by the parent organisation, although specific figures and commitments for China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. remain unspecified. In summary, while China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is part of a larger corporate family that may have climate initiatives, it currently lacks detailed emissions data and specific reduction commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000 |
| Scope 2 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000 |
| Scope 3 | - | - | - | - | - | - | - | - | 00,000,000 |
How Carbon Intensive is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s Location?
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s Scope 3 Categories Breakdown
The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Capital Goods" being the largest emissions source at 16% of Scope 3 emissions.
Top Scope 3 Categories
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
